(PharmaNewsWire.Com, June 23, 2017 ) Browse 309 market data tables and 46 figures spread through 288 pages and in-depth TOC on "Brain Monitoring Market"
Early buyers will receive 10% customization on this report.
The increasing incidence of neurological disorders, rising awareness about neurodegenerative diseases, growth in the number of traumatic brain injuries, and technological advancements are major factors driving the demand for brain monitoring devices.
On the other hand, the shortage of trained professionals to effectively operate brain monitoring devices and unfavorable reimbursement policies are restraining the growth of this market.
The brain monitoring market is segmented on the basis of product, disease type, end user, and region. On the basis of product, the market is segmented into devices and accessories. The devices segment is expected to account for the largest share of the global brain monitoring market in 2016. Factors such as increasing incidence of neurological, neurodegenerative, psychotic, and sleep disorders; the need for early diagnosis; availability of innovative portable and wearable home-based monitoring devices; and increasing patient awareness are driving the growth of this segment.
North America, comprising the U.S. and Canada, is expected to account for the largest share of the global brain monitoring market in 2016. The overall growth of the brain monitoring market in North America is primarily driven by the growing incidence of various neurodegenerative and sleep disorders, availability of insurance coverage for brain monitoring techniques, and government initiatives to support technological advancement in the field of neurosciences.
The prominent players in the brain monitoring market are Natus Medical Inc. (U.S.), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (U.K.), Siemens Healthineers (Germany), Compumedics Ltd. (Australia), Electrical Geodesics Incorporated (U.S.), Medtronic plc (Ireland), CAS Medical Systems, Inc. (U.S.), and Advanced Brain Monitoring (U.S.).
Market Stakeholders:
• Companies Manufacturing Brain Monitoring Devices and Accessories
• Healthcare Institutions (Hospitals and Outpatient Clinics)
• Distributors and Suppliers of Brain Monitoring Devices and Accessories
• Diagnostic Centers
• Neurological Centers
• Health Centers/Clinics
• Research Institutes
• Market Research and Consulting Firms
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
